Medidata Solutions Announces Parexel Has Joined Aspire to Win Program



    NEW YORK, December 20 /CNW/ - Medidata Solutions, a global provider of
electronic clinical data capture (EDC), management and reporting solutions,
today announced that PAREXEL International, a leading global biopharmaceutical
services organization, has joined Medidata's ASPire to Win(TM) program, a
non-exclusive application service provider (ASP) partnership and business
model. Through this program, Medidata will provide tools and training to
enable PAREXEL to implement Medidata Rave(R) as an EDC solution for its global
client base.

    "PAREXEL has provided EDC-driven solutions for our clients' clinical
development programs for more than a decade. EDC is now a key component of a
total eClinical solution that we believe will help the biopharmaceutical
industry realize greater improvements in efficiency and data quality in
clinical studies," said Mark A. Goldberg, M.D., President of Clinical Research
Services and Perceptive Informatics at PAREXEL. "Medidata's EDC solution has
demonstrated increasing traction in the marketplace with our client base,
across all phases of clinical research. This program will further strengthen
our knowledge of Medidata Rave technology and our ability to incorporate it as
appropriate into clinical studies."

    PAREXEL decided to formalize its relationship with Medidata by joining
the ASPire to Win program. The program enables PAREXEL to globally manage
clinical trials using Medidata Rave. PAREXEL's selection of Medidata Rave was
driven by the product's broad user acceptance, easy and fast deployment
capability and key features including real-time access to clinical data.

    "We are excited to see PAREXEL take advantage of our ASPire to Win
program, which continues to expand with the industry's increased adoption of
Medidata Rave," said Tarek Sherif, CEO of Medidata Solutions. "With this
alliance, PAREXEL will be able to help its clients conduct clinical trials
more efficiently. In addition, our clients will have access to PAREXEL's
in-depth expertise in clinical development, experience conducting thousands of
studies and access to a wide array of geographical locations in which to
conduct clinical research."

    About PAREXEL International

    PAREXEL International is a leading global bio/pharmaceutical services
organization, providing a broad range of knowledge-based contract research,
medical communications and consulting services to the worldwide
pharmaceutical, biotechnology and medical device industries. Committed to
providing solutions that expedite time-to-market and peak-market penetration,
PAREXEL has developed significant expertise across the development and
commercialization continuum, from drug development and regulatory consulting
to clinical pharmacology, clinical trials management, medical education and
reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides
advanced technology solutions, including medical imaging, to facilitate the
clinical development process. Headquartered near Boston, Massachusetts,
PAREXEL operates in 64 locations throughout 51 countries around the world, and
has approximately 7,000 employees. For more information about PAREXEL
International visit www.PAREXEL.com.

    About Medidata Solutions Worldwide

    Medidata Solutions helps the world's leading pharmaceutical,
biotechnology, medical device and research organizations maximize the value of
their clinical research investments. Innovative process design, technology and
services streamline clinical trials by providing early visibility to reliable
clinical data - the lifeblood of every research organization. Working with
companies and institutions both large and small, Medidata Solutions helps
clinical researchers safely accelerate the process of bringing life-enhancing
treatments to market - on six continents and in more than 80 countries.
Medidata Solutions brings significant value to its broad client base with deep
clinical experience and expertise in more than 20 therapeutic areas, projects
in Phase I, II, III, IV, registries and surveillance, and studies with
thousands of investigators and tens-of-thousands of subjects. For more
information, please visit www.mdsol.com.




For further information:

For further information: Lois Paul & Partners Susan Lombardo,
781.782.5767 Susan_Lombardo@lpp.com

Organization Profile

MEDIDATA SOLUTIONS WORLDWIDE

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890